Personalized medicines as percent of new molecular entities 2014-2023

This statistic displays the percentage of personalized medicines among FDA approved new molecular entities from 2014 to 2023. In 2014, personalized medicines accounted for 21 percent of the total FDA approved new molecular entities, while in 2023 they accounted for 38 percent of approved new molecular entities. The highest percentage was reported for 2018 when it stood at 42 percent.